newsfilter
← Latest News
GlobeNewswire·

23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel

ME

SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in biomarker testing and risk